Literature DB >> 16135723

Time to death, airway wall inflammation and remodelling in fatal asthma.

A L James1, J G Elliot, M J Abramson, E H Walters.   

Abstract

Fatal asthma is characterised pathologically by airway wall remodelling, eosinophil and neutrophil infiltration, accumulation of mucus in the airway lumen and smooth muscle shortening. The durations of fatal attacks of asthma show a clear bimodal distribution. Airway smooth muscle contraction and the accumulation of luminal mucus may contribute to death from asthma and relate to time to death. The current authors have examined these two components in uninflated lung tissue in cases of fatal asthma from the second Victorian asthma mortality study. Based on time from onset of symptoms to death, cases fell into two distinct groups: short course <3 (1.5+/-0.6 mean+/-sd) h; and long course >8 (12.3+/-5.9) h. Short course cases had more muscle shortening, higher levels of salbutamol and higher ratios of neutrophils to eosinophils than long course cases, who tended to have more mucus in the lumen. In conclusion, this study confirms the dichotomy of both time to death and the eosinophil/neutrophil ratio in cases of fatal asthma. It suggests that in short course cases acute airway narrowing is due, predominantly, to bronchoconstriction despite higher blood levels of salbutamol. Mucus accumulation may be more important in long course cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135723     DOI: 10.1183/09031936.05.00146404

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  13 in total

1.  Blocking the leukotriene B4 receptor 1 inhibits late-phase airway responses in established disease.

Authors:  Koichi Waseda; Nobuaki Miyahara; Arihiko Kanehiro; Genyo Ikeda; Hikari Koga; Yasuko Fuchimoto; Etsuko Kurimoto; Yasushi Tanimoto; Mikio Kataoka; Mitsune Tanimoto; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-18       Impact factor: 6.914

2.  Respiratory Enterovirus (like Parainfluenza Virus) Can Cause Chronic Lung Disease if Protection by Airway Epithelial STAT1 Is Lost.

Authors:  Yong Zhang; Dailing Mao; Shamus P Keeler; Xinyu Wang; Kangyun Wu; Benjamin J Gerovac; Laurie L Shornick; Eugene V Agapov; Michael J Holtzman
Journal:  J Immunol       Date:  2019-02-25       Impact factor: 5.422

3.  Effect of Antiasthma Simplified Herbal Medicine Intervention on neutrophil predominant airway inflammation in a ragweed sensitized murine asthma model.

Authors:  Kamal D Srivastava; David Dunkin; Changda Liu; Nan Yang; Rachel L Miller; Hugh A Sampson; Xiu-Min Li
Journal:  Ann Allergy Asthma Immunol       Date:  2014-04       Impact factor: 6.347

Review 4.  Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.

Authors:  Glenn A Jacobson; Sharanne Raidal; Morten Hostrup; Luigino Calzetta; Richard Wood-Baker; Mark O Farber; Clive P Page; E Haydn Walters
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

Review 5.  Linking acute infection to chronic lung disease. The role of IL-33-expressing epithelial progenitor cells.

Authors:  Michael J Holtzman; Derek E Byers; Jennifer-Alexander Brett; Anand C Patel; Eugene Agapov; Xiaohua Jin; Kangyun Wu
Journal:  Ann Am Thorac Soc       Date:  2014-12

6.  Asthma mortality in Australia in the 21st century: a case series analysis.

Authors:  Dianne P Goeman; Michael J Abramson; Edwina A McCarthy; Celia M Zubrinich; Jo A Douglass
Journal:  BMJ Open       Date:  2013-05-28       Impact factor: 2.692

Review 7.  Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis.

Authors:  T Umasunthar; J Leonardi-Bee; M Hodes; P J Turner; C Gore; P Habibi; J O Warner; R J Boyle
Journal:  Clin Exp Allergy       Date:  2013-12       Impact factor: 5.018

8.  Incense smoke: clinical, structural and molecular effects on airway disease.

Authors:  Ta-Chang Lin; Guha Krishnaswamy; David S Chi
Journal:  Clin Mol Allergy       Date:  2008-04-25

Review 9.  Are mast cells instrumental for fibrotic diseases?

Authors:  Catherine Overed-Sayer; Laura Rapley; Tomas Mustelin; Deborah L Clarke
Journal:  Front Pharmacol       Date:  2014-01-21       Impact factor: 5.810

10.  Risk factors for death in patients with severe asthma.

Authors:  Andréia Guedes Oliva Fernandes; Carolina Souza-Machado; Renata Conceição Pereira Coelho; Priscila Abreu Franco; Renata Miranda Esquivel; Adelmir Souza-Machado; Alvaro Augusto Cruz
Journal:  J Bras Pneumol       Date:  2014 Jul-Aug       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.